N1-Benzofused Modification of Fluoroquinolones Reduces Activity Against Gram-Negative Bacteria

• Mark Laws,
• Charlotte Hind,
• Andrea Favaron,
• Shirin Jamshidi,
• Bonnie Evans,
• Melanie Clifford,
• J. Mark Sutton,
• Khondaker Miraz Rahman

Affiliations

Mark Laws

Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King’s College London, London, U.K.

Charlotte Hind

Public Health England, National Infection Service, Research and Development Institute, Salisbury, Wiltshire, U.K.

Andrea Favaron

Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King’s College London, London, U.K.

Shirin Jamshidi

Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King’s College London, London, U.K.

Bonnie Evans

Public Health England, National Infection Service, Research and Development Institute, Salisbury, Wiltshire, U.K.

Melanie Clifford

Public Health England, National Infection Service, Research and Development Institute, Salisbury, Wiltshire, U.K.

J. Mark Sutton

Public Health England, National Infection Service, Research and Development Institute, Salisbury, Wiltshire, U.K.

Khondaker Miraz Rahman

Institute of Pharmaceutical Sciences, School of Cancer and Pharmaceutical Sciences, King’s College London, London, U.K.